These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28910526)

  • 1. Genetic rodent models of brain disorders: Perspectives on experimental approaches and therapeutic strategies.
    McGraw CM; Ward CS; Samaco RC
    Am J Med Genet C Semin Med Genet; 2017 Sep; 175(3):368-379. PubMed ID: 28910526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress.
    Millan MJ; Goodwin GM; Meyer-Lindenberg A; Ögren SO
    Eur Neuropsychopharmacol; 2015 May; 25(5):591-8. PubMed ID: 25799919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.
    Millan MJ; Goodwin GM; Meyer-Lindenberg A; Ove Ögren S
    Eur Neuropsychopharmacol; 2015 May; 25(5):599-656. PubMed ID: 25836356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-environment interactions and construct validity in preclinical models of psychiatric disorders.
    Burrows EL; McOmish CE; Hannan AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(6):1376-82. PubMed ID: 21168465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neuroanatomical approaches in models of neurodevelopmental disorders: opportunities for translation.
    Silverman JL; Ellegood J
    Curr Opin Neurol; 2018 Apr; 31(2):126-133. PubMed ID: 29493556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNV biology in neurodevelopmental disorders.
    Takumi T; Tamada K
    Curr Opin Neurobiol; 2018 Feb; 48():183-192. PubMed ID: 29331932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining psychiatric genetics: from 'mouse psychiatry' to understanding complex human disorders.
    Laporte JL; Ren-Patterson RF; Murphy DL; Kalueff AV
    Behav Pharmacol; 2008 Sep; 19(5-6):377-84. PubMed ID: 18690099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cell Technology for (Epi)genetic Brain Disorders.
    Riemens RJM; Soares ES; Esteller M; Delgado-Morales R
    Adv Exp Med Biol; 2017; 978():443-475. PubMed ID: 28523560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric comorbidities in neurodevelopmental disorders.
    King BH
    Curr Opin Neurol; 2016 Apr; 29(2):113-7. PubMed ID: 26840045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome instability and DNA repair in brain, ageing and neurological disease.
    Bohr VA; Ottersen OP; Tønjum T
    Neuroscience; 2007 Apr; 145(4):1183-6. PubMed ID: 17400394
    [No Abstract]   [Full Text] [Related]  

  • 11. Prioritizing the development of mouse models for childhood brain disorders.
    Ogden KK; Ozkan ED; Rumbaugh G
    Neuropharmacology; 2016 Jan; 100():2-16. PubMed ID: 26231830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The developing utility of zebrafish models of neurological and neuropsychiatric disorders: A critical review.
    Fontana BD; Mezzomo NJ; Kalueff AV; Rosemberg DB
    Exp Neurol; 2018 Jan; 299(Pt A):157-171. PubMed ID: 28987462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Role of Environmental Enrichment in Zebrafish Neurobehavioral Models.
    Volgin AD; Yakovlev OV; Demin KA; Abreu MS; Rosemberg DB; Meshalkina DA; Alekseeva PA; Friend AJ; Amstislavskaya TG; Kalueff AV
    Zebrafish; 2018 Oct; 15(5):425-432. PubMed ID: 30133416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removing obstacles in neuroscience drug discovery: the future path for animal models.
    Markou A; Chiamulera C; Geyer MA; Tricklebank M; Steckler T
    Neuropsychopharmacology; 2009 Jan; 34(1):74-89. PubMed ID: 18830240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zebrafish Models of Neurodevelopmental Disorders: Limitations and Benefits of Current Tools and Techniques.
    Vaz R; Hofmeister W; Lindstrand A
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we use mice to study schizophrenia?
    Canetta S; Kellendonk C
    Philos Trans R Soc Lond B Biol Sci; 2018 Mar; 373(1742):. PubMed ID: 29352031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studies.
    Homberg JR; Kyzar EJ; Stewart AM; Nguyen M; Poudel MK; Echevarria DJ; Collier AD; Gaikwad S; Klimenko VM; Norton W; Pittman J; Nakamura S; Koshiba M; Yamanouchi H; Apryatin SA; Scattoni ML; Diamond DM; Ullmann JF; Parker MO; Brown RE; Song C; Kalueff AV
    Expert Opin Drug Discov; 2016; 11(1):11-25. PubMed ID: 26558752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity.
    Rudan I
    Psychiatr Danub; 2010 Jun; 22(2):190-2. PubMed ID: 20562745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine models for human genetic neurodegenerative diseases.
    Barsoum SC; Callahan HM; Robinson K; Chang PL
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Jul; 24(5):811-23. PubMed ID: 11191715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the modeling of neurodegenerative diseases in transgenic mice.
    Duff K; Rao MV
    Curr Opin Neurol; 2001 Aug; 14(4):441-7. PubMed ID: 11470959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.